Moneycontrol PRO
Sansaar
HomeNewsBusinessStocksMax Healthcare, Godrej Ind among top losers on Nifty Midcap 150

Max Healthcare, Godrej Ind among top losers on Nifty Midcap 150

The Nifty Midcap 150 index reflected this downturn, with these stocks identified as among the top losers.

September 16, 2025 / 12:38 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Several stocks experienced declines in Tuesday's trading session, with Max Healthcare, Godrej Ind, Syngene Intl, Vodafone Idea, and BSE Limited all registering losses. The Nifty Midcap 150 index reflected this downturn, with these stocks identified as among the top losers.

Max Healthcare shares experienced a decline of 2.17%, reaching a price of Rs 1,149.90. Godrej Ind followed, with a decrease of 1.64%, bringing its share price to Rs 1,223.10. Syngene Intl saw a reduction of 1.39%, settling at Rs 661.45. Vodafone Idea's shares fell by 1.35% to Rs 8.03, while BSE Limited's shares decreased by 1.33%, resulting in a price of Rs 2,197.80.

Max Healthcare Financials:

The financial performance of Max Healthcare indicates a steady increase in revenue over the past year. Quarterly revenue has risen consistently, with the latest figure for June 2025 standing at Rs 2,027.57 Crore. This represents an increase from Rs 1,542.95 Crore in June 2024. Net profit has also shown positive trends, with the company reporting Rs 307.97 Crore in June 2025, compared to Rs 236.27 Crore in the same quarter of the previous year.

The following table summarizes the consolidated quarterly income statement:

ParticularsJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
RevenueRs 1,542.95 CroreRs 1,707.46 CroreRs 1,868.31 CroreRs 1,909.74 CroreRs 2,027.57 Crore
Other IncomeRs 34 CroreRs 40 CroreRs 33 CroreRs 46 CroreRs 36 Crore
Total IncomeRs 1,577 CroreRs 1,748 CroreRs 1,901 CroreRs 1,956 CroreRs 2,064 Crore
Total ExpenditureRs 1,232 CroreRs 1,341 CroreRs 1,540 CroreRs 1,498 CroreRs 1,608 Crore
EBITRs 345 CroreRs 407 CroreRs 361 CroreRs 457 CroreRs 455 Crore
InterestRs 23 CroreRs 33 CroreRs 52 CroreRs 55 CroreRs 54 Crore
TaxRs 85 CroreRs 91 CroreRs 70 CroreRs 83 CroreRs 92 Crore
Net ProfitRs 236 CroreRs 281 CroreRs 238 CroreRs 319 CroreRs 307 Crore

The company's annual performance shows consistent growth in revenue. For the year-ending March 2025, the revenue stood at Rs 7,028.46 Crore, a notable increase compared to Rs 5,406.02 Crore in March 2024. The net profit also saw a rise, with Rs 1,075.88 Crore reported in March 2025, up from Rs 1,057.64 Crore in the previous year.

The following table summarizes the consolidated yearly income statement:

ParticularsMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
SalesRs 2,504 CroreRs 3,931 CroreRs 4,562 CroreRs 5,406 CroreRs 7,028 Crore
Other IncomeRs 114 CroreRs 127 CroreRs 139 CroreRs 178 CroreRs 155 Crore
Total IncomeRs 2,619 CroreRs 4,058 CroreRs 4,701 CroreRs 5,584 CroreRs 7,184 Crore
Total ExpenditureRs 2,508 CroreRs 3,219 CroreRs 3,554 CroreRs 4,158 CroreRs 5,612 Crore
EBITRs 110 CroreRs 839 CroreRs 1,147 CroreRs 1,425 CroreRs 1,571 Crore
InterestRs 179 CroreRs 100 CroreRs 83 CroreRs 59 CroreRs 165 Crore
TaxRs 45 CroreRs 133 CroreRs -39 CroreRs 307 CroreRs 330 Crore
Net ProfitRs -114 CroreRs 605 CroreRs 1,103 CroreRs 1,057 CroreRs 1,075 Crore

Max Healthcare announced allotment of equity shares under Employee Stock Option Scheme 2020 on September 4, 2025.

Moneycontrol analysis indicated a bearish sentiment for Max Healthcare as of September 10, 2025.

The Nifty Midcap 150 index reflected this downturn, with these stocks identified as among the top losers.

Alpha Desk
first published: Sep 16, 2025 12:38 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347